|
(V1320) |
Sicherheit einer ununterbrochenen Rivaroxaban-Gabe bei der Katheterablation von Vorhofflimmern |
| |
|
M. Brinkmeier-Theofanopoulou, A. Radzewitz, M. Merkel, G. Schymik, C. Schmitt, A. Luik (Karlsruhe) |
|
|
Diskussion |
|
(V1321) |
Silent ischemic lesions after catheter ablation of persistent atrial fibrillation: Impact of ablation beyond pulmonary vein isolation |
| |
|
D. Schreiber, L. Brehmer, J. Fiehler, B. A. Hoffmann, A. Sultan, B. Schäffer, J. Moser, R. Ö. Akbulak, J. Lüker, D. Steven, S. Willems (Hamburg) |
|
|
Diskussion |
|
(V1322) |
The management of patients with atrial fibrillation undergoing percutaneous coronary intervention with stent implantatioN (AFCAS):
Triple therapy with LMWH-Brdiging is associated with higher risk |
| |
|
T. Kiviniemi, J. Airaksinen, A. Rubboli, J. Valencia, G. Lip, P. Karjalainen, M. Weber, M. Laine, P. Kirchhof, M. Niemelä, A. Schlitt (Turku, Pori, Helsinki, Oulu, FI; Ravenna, IT; Alicante, ES; Birmingham, UK; Groß-Umstadt, Quedlinburg) |
|
|
Diskussion |
|
(V1323) |
New Oral Anticoagulants versus Standard Therapy with Phenprocoumon during Atrial Fibrillation Ablation: Safety and Efficacy |
| |
|
M. Brunelli, A. Grosse, S. Raffa, M. Frommhold, K. Hanazawa, K. Ehrhardt, M. Kruspe, K. Raffa, D. Schwarzer, J. C. Geller (Bad Berka) |
|
|
Diskussion |
|
(V1324) |
Direct acting oral anticoagulants are more effective than Vitamin-K-antagonists for the resolution of established left atrial thrombi in patients with atrial fibrillation |
| |
|
M. Lambers, G. Nickenig, H.-J. Hertfelder, R. Schueler, D. Momcilovic, M. Weber, M. Schafigh, C. Hammerstingl (Bonn) |
|
|
Diskussion |
|
(V1325) |
Impact of left atrial appendage morphology on per-interventional thromboembolic risk during catheter ablation of atrial fibrillation |
| |
|
J. Kosiuk, S. Nedios, J. Kornej, S. Rolf, E. Koutalas, P. Sommer, A. Arya, G. Hindricks, D. Husser, A. Bollmann (Leipzig) |
|
|
Diskussion |